Advertisement

ADVERTISEMENT

breast cancer

Research in Review
High-Priority Areas for Quality Improvement Identified for Breast Cancer Treatment
07/26/2017
JCP Editors
Researchers identified three quality measures that have the largest potential of improving quality of care at a system level for patients with early-stage breast cancer receiving systemic therapy. ----- Related...
Researchers identified three quality measures that have the largest potential of improving quality of care at a system level for patients with early-stage breast cancer receiving systemic therapy. ----- Related...
...
07/26/2017
Journal of Clinical Pathways
Research in Review
Neoadjuvant Chemotherapy May Induce Breast Cancer Metastasis
07/10/2017
JCP Editors
A neoadjuvant chemotherapy combination used to treat breast cancer increases the risk of disease metastasis, according to recent research published in Science Translational Medicine (published online July 5, 2017;...
A neoadjuvant chemotherapy combination used to treat breast cancer increases the risk of disease metastasis, according to recent research published in Science Translational Medicine (published online July 5, 2017;...
A...
07/10/2017
Journal of Clinical Pathways
Research in Review
Adjuvant Ovarian Function Suppression Improves Breast Cancer Treatment Outcomes
06/29/2017
JCP Editors
In younger women with hormone receptor (HR)-positive breast cancer, ovarian function suppression (OFS) after surgery drives large improvements in breast cancer-free interval when combined with drug therapy, according...
In younger women with hormone receptor (HR)-positive breast cancer, ovarian function suppression (OFS) after surgery drives large improvements in breast cancer-free interval when combined with drug therapy, according...
In...
06/29/2017
Journal of Clinical Pathways
Research in Review
Cost-Effective Substitute for Breast Cancer MRI Identified
06/26/2017
JCP Editors
A recent analysis reports a cost-effective alternative modality that demonstrates similar efficacy to traditional breast magnetic resonance imaging (MRI), published in the American Journal of Roentgenology (June...
A recent analysis reports a cost-effective alternative modality that demonstrates similar efficacy to traditional breast magnetic resonance imaging (MRI), published in the American Journal of Roentgenology (June...
A...
06/26/2017
Journal of Clinical Pathways
Research in Review
Recent Breast Cancer HER2 Testing Guideline Update Produces Similar Positivity Rate
06/14/2017
JCP Editors
Updates to the 2013 human epidermal growth factor receptor 2 (HER2) testing guideline in breast cancer did not affect the overall positivity rate or the proportion of patients eligible for targeted therapy, according...
Updates to the 2013 human epidermal growth factor receptor 2 (HER2) testing guideline in breast cancer did not affect the overall positivity rate or the proportion of patients eligible for targeted therapy, according...
...
06/14/2017
Journal of Clinical Pathways
Research in Review
Brain Metastases Resistant to Targeted Therapy Due to Gene Overexpression
06/14/2017
JCP Editors
A novel mechanism responsible for brain metastasis resistance to targeted therapy has been identified, which may help guide treatment strategies, according to a study published in Science Translational Medicine...
A novel mechanism responsible for brain metastasis resistance to targeted therapy has been identified, which may help guide treatment strategies, according to a study published in Science Translational Medicine...
A...
06/14/2017
Journal of Clinical Pathways
Research in Review
Panel Highlights Uses of Genomic Testing for Breast Cancer
06/07/2017
JCP Editors
A panel of breast cancer experts offered an education session on the value of standard and genomic testing for breast cancer at the 2017 American Society of Clinical Oncology Annual Meeting (June 2-6, 2017; Chicago,...
A panel of breast cancer experts offered an education session on the value of standard and genomic testing for breast cancer at the 2017 American Society of Clinical Oncology Annual Meeting (June 2-6, 2017; Chicago,...
A...
06/07/2017
Journal of Clinical Pathways
Research in Review
Metastatic Breast Cancer Study Recruits Patients Via Social Media
06/04/2017
JCP Editors
A direct-to-patient approach has allowed the Metastatic Breast Cancer Project (MCBP) research study to identify nearly 3000 patients willing to provide medical records and tumor samples for analysis, according to...
A direct-to-patient approach has allowed the Metastatic Breast Cancer Project (MCBP) research study to identify nearly 3000 patients willing to provide medical records and tumor samples for analysis, according to...
A...
06/04/2017
Journal of Clinical Pathways
Research in Review
Financial Burden for Patients With Early-Stage Breast Cancer After Surveillance Testing
05/31/2017
JCP Editors
Women who have been treated for early-stage breast cancer and receive surveillance testing are at risk of adverse events and increased financial burden, according to research that will be presented at the 2017 ASCO...
Women who have been treated for early-stage breast cancer and receive surveillance testing are at risk of adverse events and increased financial burden, according to research that will be presented at the 2017 ASCO...
Women...
05/31/2017
Journal of Clinical Pathways
Research in Review
Breast Cancer HER2 Status Conversion After Neoadjuvant Chemo Guides Further Therapy
05/30/2017
JCP Editors
Patients with human epidermal growth factor 2 (HER2)-positive breast cancer who undergo induction chemotherapy are likely to convert to HER2-negative disease if residual disease occurs, prompting further systemic...
Patients with human epidermal growth factor 2 (HER2)-positive breast cancer who undergo induction chemotherapy are likely to convert to HER2-negative disease if residual disease occurs, prompting further systemic...
...
05/30/2017
Journal of Clinical Pathways

Advertisement

Advertisement

Advertisement

Advertisement

Upcoming Events

September 21 ⁠–⁠ September 22
AMP Europe
September 30 ⁠–⁠ October 2
October 1 ⁠–⁠ October 2
SAWC Fall
October 2 ⁠–⁠ October 5
October 5 ⁠–⁠ October 6
SMASH
October 14 ⁠–⁠ October 16
Lymphoma, Leukemia, and Myeloma
October 16 ⁠–⁠ October 19
October 19 ⁠–⁠ October 20
October 26 ⁠–⁠ October 27
October 29 ⁠–⁠ November 2
See Full Calendar

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use